In vitro drug metabolism testing using blood-monocyte derivatives

Bibliography

• Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 2013;138(1):103-41
   PubMed Web of Science ®Google Scholar
• Forrester LM, Henderson CJ, Glancey MJ, et al. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J 1992;281(Pt 2):359-68
   PubMedGoogle Scholar
• Worboys PD, Carlile DJ. Implications and consequences of enzyme induction on preclinical and clinical drug development. Xenobiotica 2001;31(8-9):539-56
   PubMed Web of Science ®Google Scholar
• Simonsson US, Jansson B, Hai TN, et al. Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9. Clin Pharmacol Ther 2003;74(1):32-43
   PubMed Web of Science ®Google Scholar
• Li AP, Reith MK, Rasmussen A, et al. Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin. Chem Biol Interact 1997;107(1-2):17-30
   PubMed Web of Science ®Google Scholar
• Kostrubsky VE, Ramachandran V, Venkataramanan R, et al. The use of human hepatocyte cultures to study the induction of cytochrome P-450. Drug Metab Dispos 1999;27(8):887-94
   PubMed Web of Science ®Google Scholar
• Silva JM, Morin PE, Day SH, et al. Refinement of an in vitro cell model for cytochrome P450 induction. Drug Metab Dispos 1998;26(5):490-6
   PubMed Web of Science ®Google Scholar
• Runge D, Köhler C, Kostrubsky VE, et al. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes. Biochem Biophys Res Commun 2000;273(1):333-41
   PubMed Web of Science ®Google Scholar
• Meneses-Lorente G, Pattison C, Guyomard C, et al. Utility of long-term cultured human hepatocytes as an in vitro model for cytochrome p450 induction. Drug Metab Dispos 2007;35(2):215-20
   PubMed Web of Science ®Google Scholar
• Mills JB, Rose KA, Sadagopan N, et al. Induction of drug metabolism enzymes and MDR1 using a novel human hepatocyte cell line. J Pharmacol Exp Ther 2004;309(1):303-9
   PubMed Web of Science ®Google Scholar
• Gerets HH, Tilmant K, Gerin B, et al. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol 2012;28(2):69-87
   PubMed Web of Science ®Google Scholar
• Donato MT, Lahoz A, Castell JV, Gomez-Lechon MJ. Cell lines: a tool for in vitro drug metabolism studies. Curr Drug Metab 2008;9(1):1-11
   PubMed Web of Science ®Google Scholar
• Castell JV, Jover R, Martinez-Jimenez CP, Gomez-Lechon MJ. Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies. Expert Opin Drug Metab Toxicol 2006;2(2):183-212
   PubMed Web of Science ®Google Scholar
• Kanebratt KP, Andersson TB. Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies. Drug Metab Dispos 2008;36(7):1444-52
   PubMed Web of Science ®Google Scholar
• Andersson TB, Kanebratt KP, Kenna JG. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human. Expert Opin Drug Metab Toxicol 2012;8(7):909-20
   PubMed Web of Science ®Google Scholar
• Aninat C, Piton A, Glaise D, et al. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab Dispos 2006;34(1):75-83
   PubMed Web of Science ®Google Scholar
• Hengstler JG, Brulport M, Schormann W, et al. Generation of human hepatocytes by stem cell technology: definition of the hepatocyte. Expert Opin Drug Metab Toxicol 2005;1(1):61-74
   PubMedGoogle Scholar
• Ruhnke M, Ungefroren H, Nussler A, et al. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 2005;128(7):1774-86
   PubMed Web of Science ®Google Scholar
• Ruhnke M, Nussler AK, Ungefroren H, et al. Human monocyte-derived neohepatocytes: a promising alternative to primary human hepatocytes for autologous cell therapy. Transplantation 2005;79(9):1097-103
   PubMed Web of Science ®Google Scholar
• Nussler A, Konig S, Ott M, et al. Present status and perspectives of cell-based therapies for liver diseases. J Hepatol 2006;45(1):144-59
   PubMed Web of Science ®Google Scholar
• Ek M, Soderdahl T, Kuppers-Munther B, et al. Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cells. Biochem Pharmacol 2007;74(3):496-503
   PubMed Web of Science ®Google Scholar
• Sasaki T, Takahashi S, Numata Y, et al. Hepatocyte nuclear factor 6 activates the transcription of CYP3A4 in hepatocyte-like cells differentiated from human induced pluripotent stem cells. Drug Metab Pharmacokinet 2013;28(3):250-9
   PubMed Web of Science ®Google Scholar
• Haas CE, Brazeau D, Cloen D, et al. Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction. Eur J Clin Pharmacol 2005;61(8):583-93
   PubMed Web of Science ®Google Scholar
• Benesic A, Rahm NL, Ernst S, Gerbes AL. Human monocyte-derived cells with individual hepatocyte characteristics: a novel tool for personalized in vitro studies. Lab Invest 2012;92(6):926-36
   PubMed Web of Science ®Google Scholar
• van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. J Exp Med 1968;128(3):415-35
   PubMed Web of Science ®Google Scholar
• Yona S, Jung S. Monocytes: subsets, origins, fates and functions. Curr Opin Hematol 2010;17(1):53-9
   PubMed Web of Science ®Google Scholar
• Serbina NV, Jia T, Hohl TM, Pamer EG. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008;26:421-52
   PubMed Web of Science ®Google Scholar
• Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000;406(6797):782-7
   PubMed Web of Science ®Google Scholar
• Kumar S, Jack R. Origin of monocytes and their differentiation to macrophages and dendritic cells. J Endotoxin Res 2006;12(5):278-84
   PubMedGoogle Scholar
• Morva A, Lemoine S, Achour A, et al. Maturation and function of human dendritic cells are regulated by B lymphocytes. Blood 2012;119(1):106-14
   PubMed Web of Science ®Google Scholar
• Tan JK, O'Neill HC. Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity. J Leukocyte Biol 2005;78(2):319-24
   PubMed Web of Science ®Google Scholar
• Baron JM, Zwadlo-Klarwasser G, Jugert F, et al. Cytochrome P450 1B1: a major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochem Pharmacol 1998;56(9):1105-10
   PubMed Web of Science ®Google Scholar
• Uetrecht JP. Metabolism of drugs by leukocytes. Drug Metabol Drug Interact 1994;11(4):259-82
   PubMedGoogle Scholar
• Spickett CM, Jerlich A, Panasenko OM, et al. The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids. Acta Biochim Pol 2000;47(4):889-99
   PubMed Web of Science ®Google Scholar
• Babior BM. The leukocyte NADPH oxidase. Isr Med Assoc J 2002;4(11):1023-4
   PubMed Web of Science ®Google Scholar
• Babior BM. NADPH oxidase. Curr Opin Immunol 2004;16(1):42-7
   PubMed Web of Science ®Google Scholar
• Uetrecht J, Sokoluk B. Comparative metabolism and covalent binding of procainamide by human leukocytes. Drug Metab Dispos 1992;20(1):120-3
   PubMed Web of Science ®Google Scholar
• Lichter J, Heckelen A, Fischer K, Blomeke B. Expression of N-acetyltransferase in monocyte-derived dendritic cells. J Toxicol Environ Health A 2008;71(13-14):960-4
   PubMed Web of Science ®Google Scholar
• Butcher NJ, Ilett KF, Minchin RF. Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. Mol Pharmacol 2000;57(3):468-73
   PubMed Web of Science ®Google Scholar
• Han XQ, Chung Lap Chan B, Dong CX, et al. Isolation, structure characterization, and immunomodulating activity of a hyperbranched polysaccharide from the fruiting bodies of Ganoderma sinense. J Agric Food Chem 2012;60(17):4276-81
   PubMed Web of Science ®Google Scholar
• González-Sánchez I, Solano JD, Loza-Mejía MA, et al. Antineoplastic activity of the thiazolo[5,4-b]quinoline derivative D3CLP in K-562 cells is mediated through effector caspases activation. Eur J Med Chem 2011;46(6):2102-8
   PubMed Web of Science ®Google Scholar
• Pinto MC, Dias DF, Del Puerto HL, et al. Discovery of cytotoxic and pro-apoptotic compounds against leukemia cells: tert-butyl-4-[(3-nitrophenoxy) methyl]-2,2-dimethyloxazolidine-3-carboxylate. Life Sci 2011;89(21-22):786-94
   PubMed Web of Science ®Google Scholar
• Vrba J, Modriansky M. Oxidative burst of Kupffer cells: target for liver injury treatment. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2002;146(2):15-20
   PubMedGoogle Scholar
• Shayakhmetov DM, Li ZY, Ni S, Lieber A. Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors. J Virol 2004;78(10):5368-81
   PubMed Web of Science ®Google Scholar
• Sheth K, Bankey P. The liver as an immune organ. Curr Opin Crit Care 2001;7(2):99-104
   PubMedGoogle Scholar
• Arii S, Imamura M. Physiological role of sinusoidal endothelial cells and Kupffer cells and their implication in the pathogenesis of liver injury. J Hepatobiliary Pancreat Surg 2000;7(1):40-8
   PubMedGoogle Scholar
• Willekens FL, Werre JM, Kruijt JK, et al. Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. Blood 2005;105(5):2141-5
   PubMed Web of Science ®Google Scholar
• Ding H, Tong J, Wu SC, et al. Modulation of Kupffer cells on hepatic drug metabolism. World J Gastroenterol 2004;10(9):1325-8
   PubMed Web of Science ®Google Scholar
• Hukkanen J, Pelkonen O, Hakkola J, Raunio H. Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol 2002;32(5):391-411
   PubMed Web of Science ®Google Scholar
• Piipari R, Savela K, Nurminen T, et al. Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers. Int J Cancer 2000;86(5):610-16
   PubMed Web of Science ®Google Scholar
• Oesch F, Fabian E, Oesch-Bartlomowicz B, et al. Drug-metabolizing enzymes in the skin of man, rat, and pig. Drug Metab Rev 2007;39(4):659-98
   PubMed Web of Science ®Google Scholar
• Andrade SS, Silveira RL, Schmidt CA, et al. Comparative evaluation of the human whole blood and human peripheral blood monocyte tests for pyrogens. Int J Pharm 2003;265(1–2):115-24
   PubMed Web of Science ®Google Scholar
• Hartung T, Wendel A. Detection of Pyrogens using human whole blood. ALTEX 1995;12(2):70-5
   PubMedGoogle Scholar
• Schindler S, von Aulock S, Daneshian M, Hartung T. Development, validation and applications of the monocyte activation test for pyrogens based on human whole blood. ALTEX 2009;26(4):265-77
   PubMed Web of Science ®Google Scholar
• Banerjee S, Mohanan PV. Inflammatory response to pyrogens determined by a novel ELISA method using human whole blood. J Immunol Methods 2011;369(1-2):146-53
   PubMed Web of Science ®Google Scholar
• Daneshian M, von Aulock S, Hartung T. Assessment of pyrogenic contaminations with validated human whole-blood assay. Nat Protoc 2009;4(12):1709-21
   PubMed Web of Science ®Google Scholar
• Hoffmann S, Peterbauer A, Schindler S, et al. International validation of novel pyrogen tests based on human monocytoid cells. J Immunol Methods 2005;298(1–2):161-73
   PubMed Web of Science ®Google Scholar
• Ripp SL, Mills JB, Fahmi OA, et al. Use of immortalized human hepatocytes to predict the magnitude of clinical drug-drug interactions caused by CYP3A4 induction. Drug Metab Dispos 2006;34(10):1742-8
   PubMed Web of Science ®Google Scholar
• Madan A, Graham RA, Carroll KM, et al. Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab Dispos 2003;31(4):421-31
   PubMed Web of Science ®Google Scholar
• Hariparsad N, Carr BA, Evers R, Chu X. Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction. Drug Metab Dispos 2008;36(6):1046-55
   PubMed Web of Science ®Google Scholar
• Jossé R, Aninat C, Glaise D, et al. Long-term functional stability of human HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies. Drug Metab Dispos 2008;36(6):1111-18
   PubMed Web of Science ®Google Scholar
• Ehnert S, Nussler AK, Lehmann A, Dooley S. Blood monocyte-derived neohepatocytes as in vitro test system for drug metabolism. Drug Metab Dispos 2008;36(9):1922-9
   PubMed Web of Science ®Google Scholar
• Ehnert S, Schyschka L, Noss A, et al. Further characterization of autologous NeoHepatocytes for in vitro toxicity testing. Toxicol In Vitro 2011;25(6):1203-8
   PubMed Web of Science ®Google Scholar
• Sa-ngiamsuntorn K, Wongkajornsilp A, Kasetsinsombat K, et al. Upregulation of CYP 450s expression of immortalized hepatocyte-like cells derived from mesenchymal stem cells by enzyme inducers. BMC Biotechnol 2011;11:89
   PubMedGoogle Scholar
• Song Z, Cai J, Liu Y, et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009;19(11):1233-42
   PubMed Web of Science ®Google Scholar
• Darnell M, Schreiter T, Zeilinger K, et al. Cytochrome P450-dependent metabolism in HepaRG cells cultured in a dynamic three-dimensional bioreactor. Drug Metab Dispos 2011;39(7):1131-8
   PubMed Web of Science ®Google Scholar
• Furukawa M, Nishimura M, Ogino D, et al. Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver. Cancer Sci 2004;95(6):520-9
   PubMed Web of Science ®Google Scholar